• Study Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    3 1 1 1
    Bulgaria Croatia Czechia France Germany Greece +6
  • Study Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Finland Germany Hungary +7
  • Study of GS-5245 for Treating COVID-19 in Children and Adolescents

    Not recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Hungary Italy Poland Spain
  • Study on the Effectiveness and Safety of Sodium Cromoglicate for Treating Fatigue in Multiple Sclerosis Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Italy +4
  • Study of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia France Germany Hungary Ireland Poland +1
  • Study of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

    Not recruiting

    2 1 1
    Investigated Drugs:
    France Italy Spain
  • Study of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    France Germany Ireland Italy Poland Spain
  • Study on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Belgium Bulgaria Croatia Denmark France Hungary +8
  • Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Hungary Poland Portugal +1

powered by